Medical Devices

Drug-Device Combination Products Market by Product (Drug-eluting Stent, Infusion Pump, Photodynamic Therapy, Antimicrobial Wound Dressing, Prefilled Syringe, Drug-eluting Balloon, Nebulizer, Inhaler, Transdermal Delivery System, and Others), Application (Cardiovascular Treatment, Diabetes, Respiratory Problem, Cancer Treatment, Antimicrobial Application, and Others), and End User (Hospital & Clinic, Ambulatory Surgical Center, Home Care Setting, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2025

  • ALL242557
  • 244 Pages
  • September 2018
  • Medical Devices
Download Sample    Get Discount   
 

Drug-device combination products comprise of two or more regulated components, which work in coordination. These components involve a medical device, which is used to administer a therapeutic drug in the patient's body. The drug-device combination products can be single products comprising of several components or products packed separately, intended for use with a specialized counterpart. The therapeutic drugs used along with the specific device are either mixed physically or chemically to obtain a resulting mixture for the final use. Currently, the best-known example of drug-device combination product is the drug-eluting stents that are scaffolds coated with a therapeutic drug to prevent growth of tissue scars in an artery.

The global drug-device combination products market was valued at $81,374 million in 2017 and is projected to reach $139,193 million by 2025 at a CAGR of 6.9% from 2018 to 2025. Increase in prevalence of chronic diseases such as diabetes, cardiovascular disorders, respiratory problems, and cancer, drive the growth of the global drug-device combination products market. Further, rise in geriatric population, technological advancements in drug-device combination product, and surge in homebased healthcare market are the other factors that boost the market growth. However, stringent governmental regulations for the approval of combination devices and post-complications and errors lead to numerous product recalls that hinder the growth of the global market. On the contrary, rise in healthcare infrastructure and high market potential in untapped emerging economies are anticipated to serve as lucrative opportunities for market expansion.

The global drug-device combination products market is segmented based on product, application, end user, and region. Based on product, the market is segmented into drug-eluting stent, infusion pump, photodynamic therapy, antimicrobial wound dressing, prefilled syringe, drug-eluting balloon, nebulizer, inhaler, transdermal delivery system, and other products. Drug-eluting stents are further sub-segmented into coronary drug-eluting stent and peripheral drug-eluting stent. The infusion pumps segment is further divided into implantable infusion pumps, insulin infusion pumps, patient-controlled analgesia pumps, and ambulatory infusion pumps. Similarly, prefilled syringes are further categorized into single-chamber prefilled syringes, dual-chamber prefilled syringes, and customized prefilled syringes. The drug-eluting balloons segment is bifurcated into coronary drug-eluting balloons and peripheral drug-eluting balloons. The inhalers segment is further segmented into drug powder inhalers (DPIs), metered dose inhalers (MDIs), and soft mist inhalers (SMIs). Lastly, transdermal delivery systems segment is divided into passive delivery systems and active delivery systems.

As per application, the market is categorized into cardiovascular diseases, diabetes, respiratory problems, cancer treatment, antimicrobial applications, and other applications. Considering the end-user segment, the market is segregated into hospital & clinic, ambulatory surgery center, home care setting, and other end users. Based on region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

KEY BENEFITS FOR STAKEHOLDERS

  • The study provides an in-depth analysis of the global drug-device combination products market with current trends and future estimations from 2017 to 2025 to elucidate the imminent investment pockets.
  • A comprehensive analysis of factors that drive and restrict the market growth is provided.
  • Factors instrumental in changing the market scenario, rise in opportunities, and identification of key companies that can influence this market on a global & regional scale are provided.
  • Key players are profiled, and their strategies are analyzed thoroughly to understand the competitive outlook of the market.

Key Market Segments

By Product

  • Drug-eluting stent

    • Coronary drug-eluting stent
    • Peripheral drug-eluting stent

  • Infusion pump

    • Implantable infusion pump
    • Insulin infusion pump
    • Patient-controlled analgesia pump
    • Ambulatory infusion pump

  • Photodynamic therapy
  • Antimicrobial wound dressing
  • Prefilled syringe

    • Single-chamber prefilled syringe
    • Dual-chamber prefilled syringe
    • Customized prefilled syringe

  • Drug-eluting balloon

    • Coronary drug-eluting balloon
    • Peripheral drug-eluting balloon

  • Nebulizer
  • Inhaler

    • Drug powder inhaler (DPI)
    • Metered dose inhaler (MDI)
    • Soft mist inhaler (SMI)

  • Transdermal delivery system

    • Passive delivery system
    • Active delivery system

  • Other products

By Application

  • Cardiovascular disease
  • Diabetes
  • Respiratory problem
  • Cancer treatment
  • Antimicrobial application
  • Other applications

By End user

  • Hospital & Clinic
  • Ambulatory Surgery Center (ASCs)
  • Home Care Setting
  • Other end users

By Region

  • North America

    • U.S.
    • Canada
    • Mexico

  • Europe

    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe

  • Asia-Pacific

    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific

  • LAMEA

    • Brazil
    • Saudi Arabia
    • UAE
    • Rest of LAMEA

LIST OF KEY PLAYERS PROFILED IN THE REPORT

  • Abbott Laboratories
  • Medtronic Plc
  • Smith & Nephew Plc
  • Boston Scientific Corporation
  • GlaxoSmithKline plc
  • Becton, Dickinson and Company
  • Johnson & Johnson
  • Novartis AG
  • Bayer AG
  • Baxter International, Inc.

LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request)

  • B. Braun Melsungen AG
  • Cook Medical
  • ICU Medical, Inc.
  • Moog, Inc.
  • C.R. Bard, Inc.

CHAPTER 1: INTRODUCTION

1.1. Report Description

1.2. Key Benefits for Stakeholders

1.3. Key Market Segments

1.3.1. List of key players profiled in the report

1.4. Research Methodology

1.4.1. Secondary research

1.4.2. Primary research

1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. KEY FINDINGS OF THE STUDY

2.2. CXO perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market Definition and Scope

3.2. Key findings

3.2.1. Top Winning Strategies

3.2.2. Top Investment Pockets

3.3. Top Player Positioning, 2017

3.4. Government Regulations

3.4.1. U.S. FDA

3.4.2. Europe CE Mark

3.4.3. Ministry of Health, Labor, and Welfare (MHLW)

3.4.4. Central Drug Standards Control Organization (CDSCO)

3.5. Market Dynamics

3.5.1. Drivers

3.5.1.1. Rapidly aging population and favorable demographics worldwide

3.5.1.2. Rise in incidence of chronic conditions

3.5.1.3. Technological advancements in drug-device combination products

3.5.1.4. Growth in home-based healthcare market

3.5.2. Restraints

3.5.2.1. Stringent approval process of these products

3.5.2.2. Occurrence of several errors and number of product recalls

3.5.3. Opportunities

3.5.3.1. Opportunities in emerging markets

3.5.4. Impact Analyses

3.6. Patent Analysis (2013-2018)

3.6.1. Patent analysis, by year

3.6.2. Patent analysis, by country

CHAPTER 4: DRUG-DEVICE COMBINATION PRODUCTS MARKET, BY PRODUCT

4.1. Overview

4.1.1. Market size and forecast

4.2. Drug-Eluting Stents

4.2.1. Key market trends, growth factors, and opportunities

4.2.2. Market size and forecast, by type

4.2.2.1. Coronary Drug-Eluting Stents

4.2.2.1.1. Market size and forecast

4.2.2.2. Peripheral Drug-Eluting Stents

4.2.2.2.1. Market size and forecast

4.2.3. Market size and forecast, by region

4.3. Infusion Pumps

4.3.1. Key market trends, growth factors, and opportunities

4.3.2. Market size and forecast, by type

4.3.2.1. Implantable Infusion Pumps

4.3.2.1.1. Market size and forecast

4.3.2.2. Insulin Infusion Pumps

4.3.2.2.1. Market size and forecast

4.3.2.3. Patient-controlled Analgesia Pumps

4.3.2.3.1. Market size and forecast

4.3.2.4. Ambulatory Infusion Pumps

4.3.2.4.1. Market size and forecast

4.3.3. Market size and forecast, by region

4.4. Photodynamic Therapy

4.4.1. Key market trends, growth factors, and opportunities

4.4.2. Market size and forecast, by region

4.5. Antimicrobial Wound Dressings

4.5.1. Key market trends, growth factors, and opportunities

4.5.2. Market size and forecast, by region

4.6. Prefilled Syringes

4.6.1. Key market trends, growth factors, and opportunities

4.6.2. Market size and forecast, by type

4.6.2.1. Single-Chamber Prefilled Syringes

4.6.2.1.1. Market size and forecast

4.6.2.2. Dual-Chamber Prefilled Syringes

4.6.2.2.1. Market size and forecast

4.6.2.3. Customized Prefilled Syringes

4.6.2.3.1. Market size and forecast

4.6.3. Market size and forecast, by region

4.7. Drug-Eluting Balloons

4.7.1. Key market trends, growth factors, and opportunities

4.7.2. Market size and forecast, by type

4.7.2.1. Coronary Drug-Eluting Balloons

4.7.2.1.1. Market size and forecast

4.7.2.2. Peripheral Drug-Eluting Balloons

4.7.2.2.1. Market size and forecast

4.7.3. Market size and forecast, by region

4.8. Nebulizers

4.8.1. Key market trends, growth factors, and opportunities

4.8.2. Market size and forecast, by region

4.9. Inhalers

4.9.1. Key market trends, growth factors, and opportunities

4.9.2. Market size and forecast, by type

4.9.2.1. Drug powdered inhalers (DPIs)

4.9.2.1.1. Market size and forecast

4.9.2.2. Metered dose inhalers (MDIs)

4.9.2.2.1. Market size and forecast

4.9.2.3. Soft mist inhalers (SMIs)

4.9.2.3.1. Market size and forecast

4.9.3. Market size and forecast, by region

4.10. Transdermal Delivery Systems

4.10.1. Key market trends, growth factors, and opportunities

4.10.2. Market size and forecast, by type

4.10.2.1. Active Transdermal Systems

4.10.2.1.1. Market size and forecast

4.10.2.2. Passive Transdermal Systems

4.10.2.2.1. Market size and forecast

4.10.3. Market size and forecast, by region

4.11. Other products

4.11.1. Key market trends, growth factors, and opportunities

4.11.2. Market size and forecast, by region

CHAPTER 5: DRUG-DEVICE COMBINATION PRODUCTS MARKET, BY APPLICATION

5.1. Overview

5.1.1. Market size and forecast

5.2. Cardiovascular Disorders

5.2.1. Market size and forecast, by type

5.3. Diabetes

5.3.1. Market size and forecast, by region

5.4. Respiratory Problems

5.4.1. Market size and forecast, by region

5.5. Cancer Treatment

5.5.1. Market size and forecast, by region

5.6. Antimicrobial Application

5.6.1. Market size and forecast, by region

5.7. Other Applications

5.7.1. Market size and forecast, by region

CHAPTER 6: DRUG-DEVICE COMBINATION PRODUCTS MARKET, BY END USER

6.1. Overview

6.1.1. Market size and forecast

6.2. Hospitals & Clinics

6.2.1. Market size and forecast, by region

6.3. Ambulatory Surgery Centers (ASCs)

6.3.1. Market size and forecast, by region

6.4. Home Care Settings

6.4.1. Market size and forecast, by region

6.5. Other End Users

6.5.1. Market size and forecast, by region

CHAPTER 7: DRUG-DEVICE COMBINATION PRODUCTS MARKET, BY REGION

7.1. Overview

7.1.1. Market size and forecast

7.2. North America

7.2.1. Key market trends, growth factors, and opportunities

7.2.2. North America drug-device combination products market, by country

7.2.2.1. U.S.

7.2.2.2. Canada

7.2.2.3. Mexico

7.2.3. North America market size and forecast, by product

7.2.4. North America market size and forecast, by application

7.2.5. North America market size and forecast, by end user

7.3. Europe

7.3.1. Key market trends, growth factors, and opportunities

7.3.2. Europe market size and forecast, by country

7.3.2.1. Germany

7.3.2.2. France

7.3.2.3. UK

7.3.2.4. Italy

7.3.2.5. Spain

7.3.3. Rest of Europe

7.3.4. Europe market size and forecast, by product

7.3.5. Europe market size and forecast, by application

7.3.6. Europe market size and forecast, by end user

7.4. Asia-Pacific

7.4.1. Key market trends, growth factors, and opportunities

7.4.2. Asia-Pacific market size and forecast, by country

7.4.2.1. Japan

7.4.2.2. China

7.4.2.3. India

7.4.2.4. Australia

7.4.2.5. South Korea

7.4.2.6. Rest of Asia-Pacific

7.4.3. Asia-Pacific market size and forecast, by product

7.4.4. Asia-Pacific market size and forecast, by application

7.4.5. Asia-Pacific market size and forecast, by end user

7.5. LAMEA

7.5.1. Key market trends, growth factors, and opportunities

7.5.2. LAMEA market size and forecast, by country

7.5.2.1. Brazil

7.5.2.2. Saudi Arabia

7.5.2.3. South Africa

7.5.2.4. Rest of LAMEA

7.5.3. LAMEA market size and forecast, by product

7.5.4. LAMEA market size and forecast, by application

7.5.5. LAMEA market size and forecast, by end user

CHAPTER 8: COMPANY PROFILES

8.1. Abbott Laboratories

8.1.1. Company overview

8.1.2. Company snapshot

8.1.3. Operating product segments

8.1.4. Product portfolio

8.1.5. Business performance

8.1.6. Key strategic moves and developments

8.2. Bayer AG

8.2.1. Company overview

8.2.2. Company snapshot

8.2.3. Operating product segments

8.2.4. Product portfolio

8.2.5. Business performance

8.3. Baxter International Inc.

8.3.1. Company overview

8.3.2. Company snapshot

8.3.3. Operating business segments

8.3.4. Product portfolio

8.3.5. Business performance

8.3.6. Key strategic moves and developments

8.4. Becton, Dickinson and Company

8.4.1. Company overview

8.4.2. Company snapshot

8.4.3. Operating business segments

8.4.4. Product Portfolio

8.4.5. Business performance

8.4.6. Key strategic moves and developments

8.5. Boston Scientific Corporation

8.5.1. Company overview

8.5.2. Company snapshot

8.5.3. Operating business segments

8.5.4. Product Portfolio

8.5.5. Business performance

8.5.6. Key strategic moves and developments

8.6. Johnson & Johnson

8.6.1. Company overview

8.6.2. Company snapshot

8.6.3. Operating business segments

8.6.4. Product Portfolio

8.6.5. Business performance

8.6.6. Key strategic moves and developments

8.7. Medtronic plc

8.7.1. Company overview

8.7.2. Company snapshot

8.7.3. Operating business segments

8.7.4. Product Portfolio

8.7.5. Business performance

8.7.6. Key strategic moves and developments

8.8. GlaxoSmithKline plc

8.8.1. Company Overview

8.8.2. Company snapshot

8.8.3. Operating business segments

8.8.4. Product Portfolio

8.8.5. Business performance

8.8.6. Key strategic moves and developments

8.9. Novartis International AG

8.9.1. Company overview

8.9.2. Company snapshot

8.9.3. Operating business segments

8.9.4. Product portfolio

8.9.5. Business performance

8.9.6. Key strategic moves and developments

8.10. Smith & Nephew plc

8.10.1. Company overview

8.10.2. Company snapshot

8.10.3. Operating business segments

8.10.4. Product portfolio

8.10.5. Business performance

8.10.6. Key strategic moves and developments

LIST OF TABLES

TABLE 01. MEDICAL DEVICE CLASSIFICATION IN THE U.S.

TABLE 02. GLOBAL DRUGS-DEVICE COMBINATION PRODUCTS MARKET, BY PRODUCT, 2017-2025 ($MILLION)

TABLE 03. GLOBAL DRUG-ELUTING STENTS MARKET, BY TYPE, 2017-2025 ($MILLION)

TABLE 04. DRUG-ELUTING STENTS MARKET, BY REGION, 2017-2025 ($MILLION)

TABLE 05. GLOBAL INFUSION PUMPS MARKET, BY TYPE, 2017-2025 ($MILLION)

TABLE 06. INFUSION PUMPS MARKET, BY REGION, 2017-2025 ($MILLION)

TABLE 07. PHOTODYNAMIC THERAPY SYSTEMS MARKET, BY REGION, 2017-2025 ($MILLION)

TABLE 08. ANTIMICROBIAL WOUND DRESSINGS MARKET, BY REGION, 2017-2025 ($MILLION)

TABLE 09. GLOBAL PREFILLED SYRINGES MARKET, BY TYPE, 2017-2025 ($MILLION)

TABLE 10. PREFILLED SYRINGES MARKET, BY REGION, 2017-2025 ($MILLION)

TABLE 11. GLOBAL DRUG-DEVICE COMBINATION INFUSION PUMPS MARKET, BY TYPE, 2017-2025 ($MILLION)

TABLE 12. DRUG-ELUTING BALLOONS MARKET, BY REGION, 2017-2025 ($MILLION)

TABLE 13. NEBULIZERS MARKET, BY REGION, 2017-2025 ($MILLION)

TABLE 14. GLOBAL INHALERS MARKET, BY TYPE, 2017-2025 ($MILLION)

TABLE 15. INHALERS MARKET, BY REGION, 2017-2025 ($MILLION)

TABLE 16. GLOBAL TRANSDERMAL DELIVERY SYSTEMS MARKET, BY TYPE, 2017-2025 ($MILLION)

TABLE 17. TRANSDERMAL DELIVERY SYSTEMS MARKET, BY REGION, 2017-2025 ($MILLION)

TABLE 18. OTHERS DRUG-DEVICE COMBINATION PRODUCTS MARKET, BY REGION, 2017-2025 ($MILLION)

TABLE 19. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET, BY APPLICATION, 2017-2025 ($MILLION)

TABLE 20. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET FOR CARDIOVASCULAR DISORDERS, BY REGION, 2017-2025 ($MILLION)

TABLE 21. DRUG-DEVICE COMBINATION PRODUCTS MARKET FOR DIABETES, BY REGION, 2017-2025 ($MILLION)

TABLE 22. DRUG-DEVICE COMBINATION PRODUCTS MARKET FOR RESPIRATORY PROBLEMS, BY REGION, 2017-2025 ($MILLION)

TABLE 23. DRUG-DEVICE COMBINATION PRODUCTS MARKET FOR CANCER TREATMENT, BY REGION, 2017-2025 ($MILLION)

TABLE 24. DRUG-DEVICE COMBINATION PRODUCTS MARKET FOR ANTIMICROBIAL APPLICATION, BY REGION, 2017-2025 ($MILLION)

TABLE 25. DRUG-DEVICE COMBINATION PRODUCTS MARKET FOR ANTIMICROBIAL APPLICATION, BY REGION, 2017-2025 ($MILLION)

TABLE 26. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET, BY THERAPY, 2017-2025 ($MILLION)

TABLE 27. DRUG-DEVICE COMBINATION PRODUCTS MARKET FOR HOSPITALS & CLINICS, BY REGION, 2017-2025 ($MILLION)

TABLE 28. DRUG-DEVICE COMBINATION PRODUCTS MARKET FOR AMBULATORY SURGERY CENTERS (ASCS), BY REGION, 2017-2025 ($MILLION)

TABLE 29. DRUG-DEVICE COMBINATION PRODUCTS MARKET FOR HOME CARE SETTINGS, BY REGION, 2017-2025 ($MILLION)

TABLE 30. DRUG-DEVICE COMBINATION PRODUCTS MARKET FOR OTHER END USERS, BY REGION, 2017-2025 ($MILLION)

TABLE 31. DRUG-DEVICE COMBINATION PRODUCTS MARKET, BY REGION, 2017-2025 ($MILLION)

TABLE 32. NORTH AMERICA DRUG-DEVICE COMBINATION PRODUCTS MARKET, BY COUNTRY, 2017-2025 ($MILLION)

TABLE 33. NORTH AMERICA DRUG-DEVICE COMBINATION PRODUCTS MARKET, BY PRODUCT, 2017-2025 ($MILLION)

TABLE 34. NORTH AMERICA DRUG-DEVICE COMBINATION PRODUCTS MARKET, BY APPLICATION, 2017-2025 ($MILLION)

TABLE 35. NORTH AMERICA DRUG-DEVICE COMBINATION PRODUCTS MARKET, BY END USER, 2017-2025 ($MILLION)

TABLE 36. EUROPE DRUG-DEVICE COMBINATION PRODUCTS MARKET, BY COUNTRY, 2017-2025 ($MILLION)

TABLE 37. EUROPE DRUG-DEVICE COMBINATION PRODUCTS MARKET, BY PRODUCT, 2017-2025 ($MILLION)

TABLE 38. EUROPE DRUG-DEVICE COMBINATION PRODUCTS MARKET, BY APPLICATION, 2017-2025 ($MILLION)

TABLE 39. EUROPE DRUG-DEVICE COMBINATION PRODUCTS MARKET, BY END USER, 2017-2025 ($MILLION)

TABLE 40. ASIA-PACIFIC DRUG-DEVICE COMBINATION PRODUCTS MARKET, BY COUNTRY, 2017-2025 ($MILLION)

TABLE 41. ASIA-PACIFIC DRUG-DEVICE COMBINATION PRODUCTS MARKET, BY PRODUCT, 2017-2025 ($MILLION)

TABLE 42. ASIA-PACIFIC DRUG-DEVICE COMBINATION PRODUCTS MARKET, BY APPLICATION, 2017-2025 ($MILLION)

TABLE 43. ASIA-PACIFIC DRUG-DEVICE COMBINATION PRODUCTS MARKET, BY END USER, 2017-2025 ($MILLION)

TABLE 44. LAMEA DRUG-DEVICE COMBINATION PRODUCTS MARKET, BY COUNTRY, 2017-2025 ($MILLION)

TABLE 45. LAMEA DRUG-DEVICE COMBINATION PRODUCTS MARKET, BY PRODUCT, 2017-2025 ($MILLION)

TABLE 46. LAMEA DRUG-DEVICE COMBINATION PRODUCTS MARKET, BY APPLICATION, 2017-2025 ($MILLION)

TABLE 47. LAMEA DRUG-DEVICE COMBINATION PRODUCTS MARKET, BY END USER, 2017-2025 ($MILLION)

TABLE 48. ABBOTT: COMPANY SNAPSHOT

TABLE 49. ABBOTT: OPERATING SEGMENTS

TABLE 50. ABBOTT: PRODUCT PORTFOLIO

TABLE 51. BAYER: COMPANY SNAPSHOT

TABLE 52. BAYER: OPERATING PRODUCT SEGMENTS

TABLE 53. BAYER: PRODUCT PORTFOLIO

TABLE 54. BAXTER: COMPANY SNAPSHOT

TABLE 55. BAXTER: OPERATING SEGMENTS

TABLE 56. BAXTER: PRODUCT PORTFOLIO

TABLE 57. BD: COMPANY SNAPSHOT

TABLE 58. BD: FRANCHISES

TABLE 59. BD: PRODUCT PORTFOLIO

TABLE 60. BOSTON SCIENTIFIC: COMPANY SNAPSHOT

TABLE 61. BOSTON SCIENTIFIC: OPERATING SEGMENTS

TABLE 62. BOSTON SCIENTIFIC: PRODUCT PORTFOLIO

TABLE 63. J&J: COMPANY SNAPSHOT

TABLE 64. J&J: OPERATING SEGMENTS

TABLE 65. J&J: PRODUCT PORTFOLIO

TABLE 66. MEDTRONIC: COMPANY SNAPSHOT

TABLE 67. MEDTRONIC: OPERATING SEGMENTS

TABLE 68. MEDTRONIC: PRODUCT PORTFOLIO

TABLE 69. GSK: COMPANY SNAPSHOT

TABLE 70. GSK: OPERATING SEGMENTS

TABLE 71. GSK: PRODUCT PORTFOLIO

TABLE 72. NOVARTIS: COMPANY SNAPSHOT

TABLE 73. NOVARTIS: OPERATING SEGMENTS

TABLE 74. NOVARTIS: PRODUCT PORTFOLIO

TABLE 75. SMITH & NEPHEW: COMPANY SNAPSHOT

TABLE 76. SMITH & NEPHEW: PRODUCT SEGMENTS

TABLE 77. SMITH & NEPHEW: PRODUCT PORTFOLIO

LIST OF FIGURES

FIGURE 01. DRUG-DEVICE COMBINATION MARKET SEGMENTATION

FIGURE 02. TOP WINNING STRATEGIES (2015-2018)

FIGURE 03. TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION, (2015-2018)

FIGURE 04. DETAILED STRUCTURE OF COMPANIES AND TYPE OF STRATEGIES

FIGURE 05. TOP INVESTMENT POCKETS

FIGURE 06. TOP PLAYER POSITIONING, 2017

FIGURE 07. UNDIAGNOSED PATIENT POPULATION OF DIABETES, 2015 (MILLION)

FIGURE 08. IMPACT ANALYSES

FIGURE 09. PATENTS REGISTERED/APPROVED IN THE WORLD, BY TYPE OF PRODUCT, 2013-2018

FIGURE 10. PATENTS ANALYSIS BY YEAR, 2013 THROUGH 2018

FIGURE 11. PATENT ANALYSIS, BY COUNTRY, 2013-2018

FIGURE 12. GLOBAL CORONARY DRUG-ELUTING STENTS MARKET, 2017-2025 ($MILLION)

FIGURE 13. GLOBAL PERIPHERAL DRUG-ELUTING STENTS MARKET, 2017-2025 ($MILLION)

FIGURE 14. GLOBAL IMPLANTABLE INFUSION PUMPS MARKET, 2017-2025 ($MILLION)

FIGURE 15. GLOBAL INSULIN INFUSION PUMPS MARKET, 2017-2025 ($MILLION)

FIGURE 16. GLOBAL PATIENT-CONTROLLED ANALGESIA PUMPS MARKET, 2017-2025 ($MILLION)

FIGURE 17. GLOBAL AMBULATORY INFUSION PUMPS MARKET, 2017-2025 ($MILLION)

FIGURE 18. GLOBAL SINGLE-CHAMBER PREFILLED SYRINGES MARKET, 2017-2025 ($MILLION)

FIGURE 19. GLOBAL DUAL-CHAMBER PREFILLED SYRINGES MARKET, 2017-2025 ($MILLION)

FIGURE 20. GLOBAL CUSTOMIZED PREFILLED SYRINGES MARKET, 2017-2025 ($MILLION)

FIGURE 21. GLOBAL CORONARY DRUG-ELUTING BALLOONS MARKET, 2017-2025 ($MILLION)

FIGURE 22. GLOBAL PERIPHERAL DRUG-ELUTING BALLOONS MARKET, 2017-2025 ($MILLION)

FIGURE 23. GLOBAL DRY POWDER INHALERS MARKET, 2017-2025 ($MILLION)

FIGURE 24. GLOBAL METERED DOSE INHALERS MARKET, 2017-2025 ($MILLION)

FIGURE 25. GLOBAL SOFT MIST INHALERS MARKET, 2017-2025 ($MILLION)

FIGURE 26. GLOBAL ACTIVE TRANSDERMAL SYSTEMS MARKET, 2017-2025 ($MILLION)

FIGURE 27. GLOBAL PASSIVE TRANSDERMAL SYSTEMS MARKET, 2017-2025 ($MILLION)

FIGURE 28. ESTIMATED NUMBER OF DIAGNOSED AND UNDIAGNOSED DIABETES AMONG ADULTS AGED 18 YEARS, U.S., 2015

FIGURE 29. U.S. DRUG-DEVICE COMBINATION PRODUCTS MARKET, 2017-2025 ($MILLION)

FIGURE 30. CANADA DRUG-DEVICE COMBINATION PRODUCTS MARKET, 2017-2025 ($MILLION)

FIGURE 31. MEXICO DRUG-DEVICE COMBINATION PRODUCTS MARKET, 2017-2025 ($MILLION)

FIGURE 32. LUNG CANCER INCIDENCE IN THE EUROPEAN REGION, BY GENDER, 2012 (PER 100,000 POPULATION)

FIGURE 33. GERMANY DRUG-DEVICE COMBINATION PRODUCTS MARKET, 2017-2025 ($MILLION)

FIGURE 34. FRANCE DRUG-DEVICE COMBINATION PRODUCTS MARKET, 2017-2025 ($MILLION)

FIGURE 35. UK DRUG-DEVICE COMBINATION PRODUCTS MARKET, 2017-2025 ($MILLION)

FIGURE 36. ITALY DRUG-DEVICE COMBINATION PRODUCTS MARKET, 2017-2025 ($MILLION)

FIGURE 37. SPAIN DRUG-DEVICE COMBINATION PRODUCTS MARKET, 2017-2025 ($MILLION)

FIGURE 38. REST OF EUROPE DRUG-DEVICE COMBINATION PRODUCTS MARKET, 2017-2025 ($MILLION)

FIGURE 39. JAPAN DRUG-DEVICE COMBINATION PRODUCTS MARKET, 2017-2025 ($MILLION)

FIGURE 40. CHINA DRUG-DEVICE COMBINATION PRODUCTS MARKET, 2017-2025 ($MILLION)

FIGURE 41. INDIA DRUG-DEVICE COMBINATION PRODUCTS MARKET, 2017-2025 ($MILLION)

FIGURE 42. AUSTRALIA DRUG-DEVICE COMBINATION PRODUCTS MARKET, 2017-2025 ($MILLION)

FIGURE 43. SOUTH KOREA DRUG-DEVICE COMBINATION PRODUCTS MARKET, 2017-2025 ($MILLION)

FIGURE 44. REST OF ASIA-PACIFIC DRUG-DEVICE COMBINATION PRODUCTS MARKET, 2017-2025 ($MILLION)

FIGURE 45. BRAZIL DRUG-DEVICE COMBINATION PRODUCTS MARKET, 2017-2025 ($MILLION)

FIGURE 46. SAUDI ARABIA DRUG-DEVICE COMBINATION PRODUCTS MARKET, 2017-2025 ($MILLION)

FIGURE 47. SOUTH AFRICA DRUG-DEVICE COMBINATION PRODUCTS MARKET, 2017-2025 ($MILLION)

FIGURE 48. REST OF LAMEA DRUG-DEVICE COMBINATION PRODUCTS MARKET, 2017-2025 ($MILLION)

FIGURE 49. ABBOTT: NET SALES, 2015-2017 ($MILLION)

FIGURE 50. ABBOTT: REVENUE SHARE, BY SEGMENT, 2017 (%)

FIGURE 51. ABBOTT: REVENUE SHARE, BY GEOGRAPHY, 2017 (%)

FIGURE 52. BAYER: NET SALES, 2015-2017 ($MILLION)

FIGURE 53. BAYER: REVENUE SHARE, BY SEGMENT, 2017 (%)

FIGURE 54. BAYER: REVENUE SHARE, BY GEOGRAPHY, 2017 (%)

FIGURE 55. BAXTER: NET SALES, 2015-2017 ($MILLION)

FIGURE 56. BAXTER: REVENUE SHARE, BY SEGMENT, 2017 (%)

FIGURE 57. BAXTER: REVENUE SHARE, BY GEOGRAPHY, 2017 (%)

FIGURE 58. BD: NET SALES, 2015-2017 ($MILLION)

FIGURE 59. BD: REVENUE SHARE, BY SEGMENT, 2017 (%)

FIGURE 60. BD: REVENUE SHARE, BY GEOGRAPHY, 2017 (%)

FIGURE 61. BOSTON SCIENTIFIC: NET SALES, 2015-2017 ($MILLION)

FIGURE 62. BOSTON SCIENTIFIC: NET SALES, BY SEGMENT, 2017 (%)

FIGURE 63. BOSTON SCIENTIFIC: NET SALES, BY GEOGRAPHY, 2017 (%)

FIGURE 64. J&J: NET SALES, 2015-2017 ($MILLION)

FIGURE 65. J&J: REVENUE SHARE, BY SEGMENT, 2017 (%)

FIGURE 66. J&J: REVENUE SHARE, BY GEOGRAPHY, 2017 (%)

FIGURE 67. MEDTRONIC: NET SALES, 2015-2017 ($MILLION)

FIGURE 68. MEDTRONIC: NET SALES, BY SEGMENT, 2017 (%)

FIGURE 69. MEDTRONIC: NET SALES, BY GEOGRAPHY, 2017 (%)

FIGURE 70. GSK: NET SALES, 2015-2017 ($MILLION)

FIGURE 71. GSK: REVENUE SHARE, BY SEGMENT, 2017 (%)

FIGURE 72. GSK: REVENUE SHARE, BY GEOGRAPHY, 2017 (%)

FIGURE 73. NOVARTIS: NET SALES, 2015-2017 ($MILLION)

FIGURE 74. NOVARTIS: REVENUE SHARE, BY PRODUCT, 2017 (%)

FIGURE 75. NOVARTIS: REVENUE SHARE, BY GEOGRAPHY, 2017 (%)

FIGURE 76. SMITH & NEPHEW: NET SALES, 2015-2017 ($MILLION)

FIGURE 77. SMITH & NEPHEW: REVENUE SHARE, BY PRODUCT, 2017 (%)

FIGURE 78. SMITH & NEPHEW: REVENUE SHARE, BY GEOGRAPHY, 2017 (%)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Similar Reports

Medical Implants Market By Type (Orthopedic Implants, cardiac implants, Stents, Spinal Implants, Neurostimulators, dental implants, Breast Implants, facial Implants) and By Materials (Metallic, Ceramic, Polymers, Natural) - Global Opportunity Analysis and Industry Forecast, 2014 - 2022

Medical implants are permanent devices such as pacemakers or temporary devices such as fracture plates which are removed once their function is completed. These implants are made up of bone, tissue, skin, ceramics, metals, plastics, and other natural materials...

  • Publish Date: August 21, 2016
  • $5370
Ostomy Drainage Bags Market by Type (Colostomy Bags, Ileostomy Bags, Urostomy Bags, Continent Urostomy Bags, and Continent Ileostomy Bags) - Global Opportunity Analysis and Industry Forecast, 2014-2022

Ostomy is a surgery wherein an artificial opening, known as stoma, is created from the colon in the human body to eliminate body wastes such as urine, mucus, and stools, which are collected in artificial bags called ostomy drainage bags. These plastic/rub...

  • Publish Date: December 1, 2016
  • $5370